Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03325192 · ClinicalTrials.gov registry record · NA
Rapid Pleurodesis Through an Indwelling Pleural Catheter
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03325192: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT03325192 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03325192, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The primary objective of the study is to evaluate whether the use of a rapid pleurodesis protocol using 10% iodopovidone immediately after tunneled pleural catheter placement improves time to IPC removal compared to patients who receive an IPC alone.
Interventions
- OTHER Placebo
- DRUG Rapid pleurodesis protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2019-07-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03325192
The ClinicalTrials.gov registry entry for NCT03325192 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03325192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03325192 about?
NCT03325192 is a clinical study titled "Rapid Pleurodesis Through an Indwelling Pleural Catheter". The primary objective of the study is to evaluate whether the use of a rapid pleurodesis protocol using 10% iodopovidone immediately after tunneled pleural catheter placement improves time to IPC removal compared to patients who receive an IPC alone.
What is the current status of trial NCT03325192?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2017-12-12. Estimated completion is 2019-07-09.
What interventions are being tested in trial NCT03325192?
The interventions under investigation include: Placebo (OTHER), Rapid pleurodesis protocol (DRUG).
Who is sponsoring clinical trial NCT03325192?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.